DEF: Aflac Reports Strong 2025 Adjusted Earnings, Boosts Dividend

Aflac Incorporated's 2026 Proxy Statement highlights strong 2025 financial results, including record adjusted earnings per diluted share, a 43rd consecutive dividend increase, and strategic growth initiatives in both U.S. and Japan markets.

Summary

• Net earnings for 2025 were $3.6 billion, or $6.82 per diluted share, representing a 29.2% decline year-over-year.
• Adjusted earnings per diluted share, excluding foreign currency impact, reached a record $7.49, or $7.46 (a 3.5% increase year-over-year).
• The company achieved its 43rd consecutive year of dividend increases, with the first quarter 2026 dividend raised by 5.2% to $0.61.
• Aflac deployed $3.5 billion to repurchase 33 million shares in 2025, returning a total of $4.8 billion to shareholders when combined with dividends.
• Aflac Japan's new annualized premium sales increased by 16.0%, while Aflac U.S. new annualized premium sales grew by 3.0%.
• A June 2025 cybersecurity incident impacted a limited number of company systems, with threat actors removed within hours, but led to class-action lawsuits.
• New products launched in Japan include Miraito (cancer policy in March 2025) and Anshin Palette (medical product in late December 2025), alongside the repricing of Tsumitasu in September 2025.
• The company maintains strong capital positions with Aflac Japan's Solvency Margin Ratio (SMR) at 995% and Aflac U.S. Combined Risk-Based Capital (RBC) Ratio at 570%.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, particularly in adjusted earnings and shareholder returns, despite a decline in GAAP net earnings. Strategic product launches and robust capital management initiatives contribute to a positive outlook.

Positives

• Adjusted earnings per diluted share (ex-FX) reached $7.49, marking the best year in company history, and increased 3.5% year-over-year to $7.46.
• Achieved 43rd consecutive year of dividend increases, with the Q1 2026 dividend raised by 5.2% to $0.61.
• Deployed $3.5 billion to repurchase 33 million shares, delivering $4.8 billion back to shareholders in 2025 (combined with dividends).
• Aflac Japan's new annualized premium sales increased by 16.0%, reflecting robust sales of new products.
• Aflac U.S. new annualized premium sales increased by 3.0%, indicating continued growth in the domestic market.
• Maintained a strong Adjusted Return on Equity (AROE) ex-FX of 17.5%.
• Aflac Japan Solvency Margin Ratio (SMR) of 995% and Aflac U.S. Combined Risk-Based Capital (RBC) Ratio of 570% demonstrate robust capital strength.
• Successfully launched new products in Japan: Miraito (cancer policy) in March 2025 and Anshin Palette (medical product) in late December 2025.
• Recognized as one of the World's Most Ethical Companies by Ethisphere for the 20th consecutive year, the only insurance company to hold this honor every year since 2007.
• Three-year Total Shareholder Return (TSR) was 63.8%, significantly outperforming the S&P 500 Life & Health Insurance index (34.3%).

Negatives

• Net earnings declined to $3.6 billion, or $6.82 per diluted share, a 29.2% decrease year-over-year.
• Aflac Japan's net earned premiums decreased by 3.9% due primarily to the 2024 reinsurance transaction and first sector policies reaching paid-up status.
• Aflac U.S. net earned premium increase of 2.9% was below the target Management Incentive Plan (MIP) goal.
• A June 2025 cybersecurity incident impacted a limited number of company systems, leading to class-action lawsuits alleging negligence and under-spending on digital security.
• Credit losses/impairments for Global Investments were $209 million, resulting in a payout between minimum and target for MIP.
• The Board of Directors recommended a vote AGAINST a shareholder proposal for an independent Board Chairman.

Risks

• Cybersecurity risks, as evidenced by the June 2025 incident and subsequent class-action lawsuits, pose a threat to information assets, customer data, and reputation.
• Investment risks, including liquidity risk, market risk, and credit risk, are inherent in managing a large investment portfolio and are subject to economic environment fluctuations.
• Regulatory and legislative risks are significant given the highly regulated nature of the insurance industry in both the U.S. and Japan.
• Geopolitical environments can present challenges to executing strategic priorities.
• Artificial intelligence (AI) introduces new risks that the Board is actively overseeing.
• Foreign currency fluctuations, particularly the yen/dollar exchange rate, can significantly affect reported U.S. GAAP revenue, earnings, assets, book value, and cash flow.
• Competition in the supplemental insurance markets of the U.S. and Japan requires continuous product innovation and distribution strengthening.

Future Outlook

Management believes in the underlying strengths of the company's business and potential for continued growth in Japan and the U.S., two of the largest life insurance markets. The Board is actively working with management to position the company for future opportunities and to meet evolving consumer needs. The company expects continued sales growth in Aflac U.S. and anticipates Aflac Japan's third sector sales to grow due to an extensive product lineup and expanded sales agent network. Artificial intelligence remains a frequent topic of discussion for the Board, indicating its potential impact on future operations and risks.

Management Comments

• Daniel P. Amos, Chairman and CEO: "2025 was yet another year in our seven-plus decade history that our management, employees and sales distribution teams pressed on as dedicated champions of our business to accomplish our goal: providing the best value in supplemental insurance products in the United States and Japan."
• Daniel P. Amos, Chairman and CEO: "While delivering value to our policyholders, the Company generated $3.6 billion in net earnings, or $6.82 per diluted share, in 2025. As a result, net earnings per diluted share declined 29.2%. Adjusted earnings per diluted share* were $7.49, the best year in history, and adjusted earnings per diluted share excluding the impact of foreign currency* were $7.46, which was a 3.5% increase year over year."
• Daniel P. Amos, Chairman and CEO: "2025 marked the 43rd consecutive year of dividend increases. We treasure our track record of dividend growth and remain committed to extending it, supported by the strength of our capital and cash flows."
• W. Paul Bowers, Lead Non-Management Director: "The Company and our Management team's preparedness activities allowed for a timely response to a June 2025 cybersecurity incident impacting a limited number of Company systems, with removal of the threat actors within hours."
• W. Paul Bowers, Lead Non-Management Director: "artificial intelligence (AI) was a very frequent topic in our discussions in 2025 and remains so today."
• W. Paul Bowers, Lead Non-Management Director: "The Aflac Global Investments team has built a high-quality, all-weather portfolio that we believe supports our promise to our policyholders no matter the economic environment."

Industry Context

StockSavvy.ai notes that Aflac's strong adjusted earnings and consistent dividend growth in 2025 demonstrate resilience in the competitive supplemental insurance markets of the U.S. and Japan. The focus on new product development like Miraito and Anshin Palette in Japan aligns with broader industry trends of product innovation to attract younger demographics and address evolving healthcare needs. The reported cybersecurity incident, while contained, underscores the increasing threat landscape faced by financial services and insurance companies globally, necessitating robust digital security investments. Aflac's continued recognition as one of the World's Most Ethical Companies positions it favorably against competitors in an industry where trust and corporate responsibility are increasingly valued by consumers and investors.

Comparison to Industry Standards

• Aflac's 3-year Total Shareholder Return (TSR) of 63.8% significantly outperformed the S&P 500 Life & Health Insurance index's 34.3% over the same period, indicating strong relative performance.
• The company's adjusted leverage ratio of 21.4% falls within a conservative range of 20% to 25%, suggesting a prudent capital structure compared to industry peers.
• Aflac Japan's Solvency Margin Ratio (SMR) of 995% and Aflac U.S. Combined Risk-Based Capital (RBC) Ratio of 570% are described as 'among the highest in the industry,' implying a strong capital position relative to global benchmarks for insurance companies.
• The company's 43rd consecutive year of dividend increases places it in an elite group of dividend-growth companies, far exceeding the average for the insurance sector.
• Aflac's consistent recognition as one of the 'World's Most Ethical Companies' for 20 consecutive years by Ethisphere is a unique achievement, making it the 'only insurance company in the world' to hold this distinction every year since 2007, setting a high standard for corporate ethics in the industry.

Management Changes

Corporate Governance

Legal Proceedings

• Multiple class-action lawsuits were filed against Aflac following the June 2025 cybersecurity incident, accusing the company of negligence, breach of contract, and invasion of privacy.

Related Party Transactions

• Sabrina Pasini Brodn, spouse of CFO Max K. Brodn, is employed as Director, Digital Marketing, with total compensation of $237,691 in 2025, which is commensurate with her peers.
• A strategic alliance with Japan Post Holdings Co., Ltd. (Japan Post Holdings) involves a capital relationship and commercial arrangements since December 19, 2018.
• Japan Post Holdings committed to acquire approximately 7% of Aflac's outstanding Common Stock via a trust, and as of December 31, 2020, the Trust beneficially acquired 7.45% of Common Stock.
• The Trust's voting rights are restricted to no more than 20% of the company's voting rights, and it has agreed not to beneficially own more than the greater of 10% of outstanding shares and shares representing 22.5% of voting rights.
• Aflac Japan's cancer insurance policies sold through Japan Post Holdings affiliates constituted approximately 6.7% of Aflac Japan's earned premium for 2025, representing about 3.3% of Aflac Incorporated's total consolidated earned premium.
• Japan Post Holdings affiliates collectively received approximately $102 million in commission and other payments from Aflac Japan and its affiliates during 2025 for facilitating sales and other services.
• Japan Post Holdings has 90 days from February 25, 2026, to transfer shares it beneficially owns to move below the 10% ownership threshold of the company's outstanding shares of Common Stock.

Stakeholder Impact

• Shareholders are directly impacted by the 43rd consecutive dividend increase, $3.5 billion in share repurchases, and a 3-year TSR of 63.8%, indicating strong returns. The cybersecurity incident and related lawsuits could affect shareholder confidence and future financial performance.
• Policyholders and customers benefit from new product launches like Miraito and Anshin Palette, and support initiatives such as 'Check for Cancer' and 'Yori-sou Cancer Consultation Support.' However, the cybersecurity incident put customer data at risk, potentially impacting trust.
• Employees are affected by compensation programs, including base salary increases for some executives, and the company's commitment to continuous development and wellness opportunities. The 'World's Most Ethical Companies' recognition can enhance employee morale.
• Management's compensation is directly linked to company performance through incentive plans, aligning their interests with strategic goals and shareholder value.
• Regulatory authorities in the U.S. and Japan are key stakeholders, with the company's strong capital ratios (SMR, RBC) demonstrating compliance and financial stability. The cybersecurity incident may lead to increased regulatory scrutiny.
• Communities benefit from Aflac's corporate social responsibility efforts, including significant contributions to the Aflac Cancer and Blood Disorders Center and the 'My Special Aflac Duck' program.

Next Steps

• The Annual Meeting of Shareholders will be held on May 4, 2026, to elect directors, vote on executive compensation, ratify auditors, and consider a shareholder proposal.
• Shareholders are encouraged to review proxy materials and the Annual Report on Form 10-K and vote in advance of the meeting.
• The Corporate Governance Committee will continue to oversee the annual assessment of Board performance.
• The Compensation Committee will continue to review the executive compensation program annually to determine if additional changes are warranted.
• The company will continue to engage with shareholders to understand their perspectives on business, strategy, management, Board, and governance practices.
• Japan Post Holdings has 90 days from February 25, 2026, to transfer shares it beneficially owns to move below the 10% ownership threshold of the company's outstanding shares of Common Stock.

Key Dates

Recommendation

Aflac demonstrated strong operational performance in 2025 with record adjusted earnings per diluted share and a significant 43rd consecutive dividend increase, alongside substantial share repurchases. This indicates robust capital management and a commitment to shareholder returns. However, the decline in GAAP net earnings and the cybersecurity incident, which led to class-action lawsuits, introduce an element of uncertainty and potential future costs. While strategic initiatives in Japan are promising, the decrease in Japan's net earned premiums warrants close monitoring. The stock has outperformed its peer index over three years, suggesting it is likely fairly valued. Given the mixed signals of strong adjusted performance against GAAP declines and emerging legal/cyber risks, a 'hold' recommendation is appropriate for seasoned investors to observe how these factors evolve.

Keywords

Aflac, insurance, supplemental insurance, Japan, U.S., cancer insurance, financial services, dividends, share repurchase, executive compensation, corporate governance, cybersecurity, risk management, proxy statement, AROE, EPS, SMR, RBC, shareholder return